OACC · XBRL financial data
Oaktree Acquisition Corp. III Life Sciences financial statements, every quarter
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (OACC's year ends in late December)
Balance sheet
CSVFiscal quarters (OACC's year ends in late December)
| In thousands of dollars | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1,281 | 1,385 | 1,329 | 1,435 | 1,277 | 1,180 |
| Total current assets | 1,482 | 1,561 | 1,481 | 1,548 | 1,416 | 1,260 |
| Total assets | 197,241 | 199,176 | 201,250 | 203,112 | 204,830 | 206,541 |
| Total current liabilities | 1,059 | 1,119 | 1,227 | 1,300 | 1,624 | 1,730 |
| Total liabilities | 8,077 | 8,138 | 8,246 | 8,318 | 8,643 | 8,749 |
| Accumulated deficit | (6,520) | (6,540) | (6,765) | (6,771) | (7,227) | (7,489) |
| Total stockholders' equity | (6,519) | (6,539) | (6,765) | (6,770) | (7,227) | (7,489) |
| Total liabilities and equity | 197,241 | 199,176 | 201,250 | 203,112 | 204,830 | 206,541 |
Cash flows
CSVFiscal quarters (OACC's year ends in late December)
| In thousands of dollars | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Net income (loss) | 1,659 | 1,874 | 1,967 | 1,789* | 1,394 | 1,605 |
| Net cash from operating activities | (76) | (146)* | (57)* | (144)* | (158) | (97)* |
| Net cash from investing activities | — | — | 0* | 250* | — | — |
| Net cash from financing activities | — | — | — | year only | — | — |
Compare with peers
SIC 6770 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 6770 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Oaktree Acquisition Corp. III Life Sciences | 1,180 | not reported | (97)* | not reported | 12.1 quarters | 10-QJun 30, 2026 |
| Vendome Acquisition Corp I | 302 | not reported | (136)* | not reported | 2.2 quarters | 10-QJun 30, 2026 |
| Blue Acquisition | 202 | not reported | (157)* | not reported | 1.3 quarters | 10-QJun 30, 2026 |
| Axiom Intelligence Acquisition Corp 1 | 290 | not reported | (256)* | not reported | 1.1 quarters | 10-QJun 30, 2026 |
| NewHold Investment Corp. III | 364 | not reported | (260)* | not reported | 1.4 quarters | 10-QJun 30, 2026 |
| Siddhi Acquisition Corp (Cayman Islands) | 168 | not reported | (214)* | not reported | 0.8 quarters | 10-QJun 30, 2026 |
| Legato Merger Corp. III | 519 | not reported | (321) | 25.8M | 1.6 quarters | 10-QFeb 28, 2026 |
| LightWave Acquisition | 473 | not reported | (153)* | not reported | 3.1 quarters | 10-QJun 30, 2026 |
| SilverBox Corp IV | 15 | not reported | (117)* | not reported | 0.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.